Progression Free Survival - an overview | ScienceDirect Topics
Endpoints Used in Clinical Trials Endpoint Definition Overall survival... | Download Table
Kaplan–Meier plots for overall survival among patients who were... | Download Scientific Diagram
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework | British Journal of Cancer
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Clinical Trial Endpoints for Oncology Studies
CDISC SDTM and ADaM for survival data - ppt download
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
![PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30f4b9adffa198bf79a177643e74ec64b4107203/3-Table1-1.png "PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar")
PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
Survival in oncology reimbursement decision-making | CMAR
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Time to second subsequent therapy as an endpoint. Progression-free... | Download Scientific Diagram
JCM | Free Full-Text | Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer | Journal of Clinical Oncology
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 | Journal of Clinical Oncology
Frontiers | What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
